European Medical Journal
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)(Learn how and when to remove this template message)
Abbreviated title (ISO 4)
The European Medical Journal (EMJ) is an open-access, medical eJournal that provides peer-reviewed resources to thousands of medical professionals in Europe. Founded in 2012, as an imprint of the European Medical Group (EMG), all publications feature editorials from key opinion leaders, a scientific papers covering a wide range of therapeutic areas, and concise news coverage from congresses within the industry.
The European Medical Journal currently publishes eJournals across 16 different therapeutic areas, along with a collection of material in its flagship eJournal EMJ, the first edition of which debuted in January 2016. New to January 2017, will be EMJ Innovations, delivering content consisting of pioneering medical technologies, and breakthroughs in medical areas such as human genetics, infectology, and precision medicine, to name but a few.
Each eJournal is published six weeks after its relevant congress takes place.
- EMJ – Allergy & Immunology
- EMJ – Cardiology
- EMJ – Dermatology
- EMJ – Diabetes
- EMJ – Gastroenterology
- EMJ – Hematology
- EMJ – Hepatology
- EMJ - Interventional Cardiology
- EMJ – Medical Innovations
- EMJ – Neurology
- EMJ – Nephrology
- EMJ – Oncology
- EMJ – Reproductive Health
- EMJ – Respiratory
- EMJ – Rheumatology
- EMJ – Urology
To bring the latest in medical news and developments from across the fields, EMJ runs a daily newsletter, in addition to a quarterly newsletter for each therapeutic area. EMJ also regularly publishes medical news updates.
In 2014, EMJ introduced their new and improved blog. With contributors ranging from doctors and academics, to students and patients, blog pieces are shared with a wider audience, detailing everything from research articles, medical conditions and personal experiences.
Using Twitter as their main port of communication, EMJ currently has sixteen therapeutic area pages, in addition to a general healthcare page; utilising health news sites to share the latest in medical developments, along with EMJ publications and video content.
EMJ’s facebook page offers a social media platform for followers to network with like-minded medical professionals, hosting the latest medical news and healthcare developments, in addition to providing a platform for the company to share its publications.
EMJ’s LinkedIn group is an exclusive platform for medical professionals to connect, and join in daily discussions surrounding the latest in medical developments. Members are encouraged to share their thoughts and interests in the group, contributing posts relevant to the field of medicine.
Similarly, to EMJ’s Facebook, Google + offers a social media platform for followers to network with like-minded medical professionals, hosting the latest medical news and healthcare developments, in addition to providing a platform for the company to share its publications.
EMJ’s YouTube page primarily consists of interviews with key opinion leaders at medical congresses, in addition to medical discussions chaired at congress, and general congress reviews.